Trial Site Detail

 

Drug:
Ripretinib plus Binimetinib
Trial:
Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Withdrawn

 

University of Miami, Sylvester Comprehensive Cancer Center

1475 Northwest 12th Ave     
Miami , FL 33136
USA

 

Principal Investigator:
Jonathan Trent, MD, PhD
Contact:
Activation Status of this Site:
Not yet activated
Notes about this Site:
University of Miami, Sylvester Comprehensive Cancer Center Website:
http://uhealthsystem.com/clinical-trials/browse-clinical-trials/results?tarea=Bone%20and%20Soft%20Tissue%20Cancers&division=Cancer%20Center

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.